I. Sandler

Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen

C. Kovacs, M. Loutfy, B. Varriano, 2019, International journal of STD & AIDS.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2017, BMC Infectious Diseases.

Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring

J. Fay, G. Saracino, E. Vance, 2005, Bone Marrow Transplantation.

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

P. Harrigan, B. Yip, R. Hogg, 2016, BMC Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles

C. Kovacs, M. Loutfy, W. Barrie, 2016, HIV clinical trials.

Bank Interconnectedness and Monetary Policy Transmission: Evidence from the Euro Area Master Project International Trade, Finance, and Development

I. Sandler, Michael Barczay, G. Galambos, 2019 .